Found 267 matching trials
TReatment by Insulin Continuous Infusion in Type 2 DIAbetes PHASE4 The aim of the TRICIDIA2 study is to compare two modalities of administrati...
Show More Learn More & Join Trial
21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus PHASE2 Single Center, Double Blind, Active Comparator Controlled 2-Way Crossover M...
Show More Location
Atlanta Diabetes Association
Learn More & Join Trial
Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes PHASE2 In the unfortunate case of severe hypoglycaemia, glucagon is the first-line...
Show More Location
Institut de recherches cliniques de Montréal
Learn More & Join Trial
Sigi Insulin Management System - A First-in-Human Study in Adults With Type 1 Diabetes NA This early feasibility first-in-human study is a prospective single-arm sin...
Show More Location
Multiple Locations
Learn More & Join Trial
Artificial Pancreas in Latin America NA The purpose of this study is to use closed-loop systems with the algorithms...
Show More Location
Multiple Locations
Learn More & Join Trial
NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes PHASE4 This trial is conducted in the United States of America (USA). The aim of t...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy PHASE3 The reason for this study is to compare the study drug LY900014 to insulin ...
Show More Location
John Muir Physician Network Clinical Research Center
Learn More & Join Trial
Impact of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification PHASE4 Despite advances in diabetes management, many patients with type 2 diabetes...
Show More Location
Department of endocrinology, FAH-SYSU
Learn More & Join Trial
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) PHASE4 The primary objectives of this study are to compare the difference in glyco...
Show More Location
For additional information regarding investigative sites for this trial, call (858) 794-8889 8 AM to 5 PM Mon-Fri Pacific Standard Time
Learn More & Join Trial
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients PHASE2 This was a four month dose ranging study followed by a 24 to 48 month exten...
Show More Location
Anasazi Internal Medicine
Learn More & Join Trial